
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Worldwide Clinical Trials, Inc-a global CRO- and Deep Lens-an AI-driven digital pathology company-announced an alliance in oncology. The companies will work in tandom using Worldwide’s knowledge in clinical cancer research and global clinical trial operations with the Deep Lens VIPER digital pathology platform.
Read the full release






